The impact of long-term gonadotropin-releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization-embryo transfer

To examine the relationship between endometriosis and preclinical abortions and to evaluate the effect of gonadotropin-releasing hormone analogue (GnRH-a) therapy on these pregnancies. Of 67 women with severe endometriosis referred to us for in vitro fertilization-embryo transfer (IVF-ET), 32 underw...

Full description

Saved in:
Bibliographic Details
Published inFertility and sterility Vol. 57; no. 3; pp. 597 - 600
Main Authors Dicker, Dov, Goldman, Jack A., Levy, Tally, Feldberg, Dov, Ashkenazi, Jacob
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.03.1992
Elsevier Science
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To examine the relationship between endometriosis and preclinical abortions and to evaluate the effect of gonadotropin-releasing hormone analogue (GnRH-a) therapy on these pregnancies. Of 67 women with severe endometriosis referred to us for in vitro fertilization-embryo transfer (IVF-ET), 32 underwent ovarian stimulation for oocyte retrieval with menotropins (protocol A), whereas the other 35 were admitted for the procedure after a 6-month period of hormonal suppression with a GnRH agonist (protocol B). The clinical impact of the preclinical and clinical pregnancies in both treatment protocols were evaluated on the basis of oocyte classification and embryo quality score. All patients were treated in our IVF Unit. Clinical pregnancy was used as our main outcome measure of success. A significantly higher number of preclinical pregnancies (P<0.0001) occurred in patients treated by protocol A. After GnRH-a treatment, the preclinical pregnancy rate declined significantly (P<0.0001), whereas the clinical pregnancy rate per cycle and per transfer rose significantly (P<0.0001 and P<0.0001, respectively). Furthermore, clinical pregnancies had a significantly better mean embryo quality score in comparison with preclinical pregnancies (P<0.0001). It is concluded that combining GnRH-a therapy before IVF-ET provides an improved treatment modality for preclinical abortions and infertility associated with severe endometriosis.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
ObjectType-News-3
content type line 23
ISSN:0015-0282
1556-5653
DOI:10.1016/S0015-0282(16)54906-1